A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-4597 Inhalation in Healthy Subjects and Asthmatic Patients

NCT06385964 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects
Asthmatic Patients

Interventions

DRUG: SHR-4597
DRUG: Placebo

Sponsor

Guangdong Hengrui Pharmaceutical Co., Ltd